Schizophrenia Research

Schizophrenia is a chronic, debilitating mental disorder affecting 1-2% of the global population. Symptoms are split into two types; 'positive' symptoms, including delusions and hallucinations, and 'negative' symptoms, including anhedonia and lack of motivation. Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Several neurobiological alterations in brain structure, physiology and neurochemistry have been documented, along with an ever-increasing list of susceptibility genes.

Schizophrenia Research Products Targets

Products for Schizophrenia Research - Page 52

  1. Cat.No. Product Name Information/Activity
  2. BCC5051 Lamotrigine Lamotrigine(BW430C) is a novel anticonvulsant drug for inhibition of 5-HT and sodium channel Target: Sodium Channel Lamotrigine stabilises presynaptic neuronal membranes by blockade of voltage-dependent sodium channels, thus preventing the release of excitatory neurotransmitters, particularly glutamate and aspartate [1]. Lamotrigine chemical structure
  3. BCC7086 MNI-caged-L-glutamate 295325-62-1 MNI-caged-L-glutamate chemical structure
  4. BCC7453 Pentylenetetrazole 54-95-5 Pentylenetetrazole chemical structure
  5. BCC6731 Salsolinol-1-carboxylic acid 57256-34-5 Salsolinol-1-carboxylic acid chemical structure
  6. BCC6632 Spaglumic acid Spaglumic Acid is a neuropeptide found in millimolar concentrations in brain. Spaglumic acid chemical structure
  7. BCN2571 L-Theanine L-Theanine (L-Glutamic Acid γ-ethyl amide)is a non-protein amino acid contained in green tea leaves, which blocks the binding of L-glutamic acid to glutamate receptors in the brain, and with neuroprotective and anti-oxidative activities. L-Theanine causes anti-stress effects via the inhibition of cortical neuron excitation by oral intake. L-Theanine chemical structure
  8. BCC2512 Zonisamide Zonisamide is a 1,2 benzisoxazole derivative and the first agent of this chemical class to be developed as an antiepileptic drug. Zonisamide chemical structure
  9. BCC6566 cis-ACPD 477331-06-9 cis-ACPD chemical structure
  10. BCC2894 H-D-Asp-OH (-)-Aspartic acid is an endogenous NMDA receptor agonist. H-D-Asp-OH chemical structure
  11. BCC2881 H-Asp-OH L-Aspartic acid is is an amino acid, shown to be a suitable prodrug for colon-specific drug deliverly. H-Asp-OH chemical structure

Items 511 to 520 of 709 total